DocSym
β
Searchsearch
Search
(B46.1) Rhinocerebral mucormycosis
More details coming soon
1 727 in individuals diagnosis rhinocerebral mucormycosis confirmed
2 784 deaths with diagnosis rhinocerebral mucormycosis
161% mortality rate associated with the disease rhinocerebral mucormycosis
Diagnosis rhinocerebral mucormycosis is diagnosed Men are 28.20% more likely than Women
1 107
Men receive the diagnosis rhinocerebral mucormycosis
2 068 (186.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
620
Women receive the diagnosis rhinocerebral mucormycosis
716 (115.5 %)Died from this diagnosis.
Risk Group for the Disease rhinocerebral mucormycosis - Men aged 15-19 and Women aged 65-69
In Men diagnosis is most often set at age 15-19, 35-39, 50-59
Less common in men the disease occurs at Age 0-14, 20-34, 40-49, 60-95+Less common in women the disease occurs at Age 0-64, 70-95+
In Women diagnosis is most often set at age 65-69
Disease Features rhinocerebral mucormycosis
Absence or low individual and public risk
Rhinocerebral mucormycosis - what does this mean
Rhinocerebral mucormycosis is a rare but serious fungal infection that typically occurs in immunocompromised individuals, particularly those with diabetes. it is caused by the inhalation of fungal spores, usually from the environment, which then enter the sinuses and spread to the brain. symptoms can include fever, headache, facial pain, nasal congestion, and black lesions on the mucous membranes.
What happens during the disease - rhinocerebral mucormycosis
Rhinocerebral mucormycosis is a rare but life-threatening fungal infection caused by a group of molds called mucormycetes. it usually occurs in people with weakened immune systems, such as those with uncontrolled diabetes, cancer, or hiv/aids. the infection is typically caused by inhalation of airborne spores from the environment, which can then travel to the sinuses and invade the tissues of the face, leading to tissue destruction, inflammation, and necrosis. this can cause damage to the facial bones, eyes, and brain, leading to severe symptoms such as fever, headache, facial swelling, and visual disturbances.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the affected area
- Imaging studies such as CT scan or MRI
- Blood tests to check for markers of infection
- Biopsies of affected tissue to confirm diagnosis
- Tissue culture to identify the type of fungus causing the infection
- Serum and urine antigen testing
- Fungal cultures of the sinuses and nasal cavities
Treatment and Medical Assistance
Main Goal: Treat Rhinocerebral Mucormycosis
- Administer antifungal medications such as amphotericin B and posaconazole
- Remove affected tissues surgically
- Administer corticosteroids to reduce inflammation
- Administer antibiotics to treat any secondary bacterial infections
- Provide supportive care such as oxygen therapy, nutritional support, and blood pressure control
- Monitor for any complications such as brain abscess or meningitis
- Provide psychological support for the patient
38 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Rhinocerebral mucormycosis - Prevention
Rhinocerebral mucormycosis can be prevented by controlling diabetes, avoiding contact with contaminated soil, avoiding inhalation of airborne spores, and using antifungal medications if prescribed by a doctor.